Tuesday, February 9, 2010, 11:14pm EST - Canadian Markets are closed.
To create a watchlist or portfolio of shares, Sign-in or Register

Cyberonics Inc. (CYBX)

 At 16:00 EST: 17.60 USD  Up 0.23 (1.32%)  
MORE ON CYBX
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Cyberonics, Inc. (NGM:CYBX) Delayed quote dataEdit
After Hours: 17.60 0.00 (0.00%) as of 4:34pm EST on 02/09/10
Last Trade: 17.60 USD
Trade Time: 4:00PM EST
Change: Up 0.23 (1.32%)
Prev Close: 17.37
Open: 17.62
Bid: 17.19 x 200
Ask: 17.99 x 200
1y Target Est: 14.70
Day's Range: 17.31 - 17.63
52wk Range: 12.31 - 21.63
Volume: 190,554
Avg Vol (3m): 241,627
Market Cap: 488.47M
P/E (ttm): N/A
EPS (ttm): -1.63
Div & Yield: N/A (N/A%)
Cyberonics Inc. (CYBX)
1d  5d  3m  6m  1y  2y  5y  max 
 Add CYBX to Portfolio   Download Data

HEADLINES
• Supply & Demand Profits and 3 PowerRatings Stocks
TradingMarkets.com (Thu, Feb 4)
• Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 Third Quarter Financial Results
PRNewswire (Wed, Feb 3)
• Deathbed Stocks Revisited
at Motley Fool (Fri, Jan 29)
• Cyberonics receives Japanese approval for VNS Therapy Solutions
at bizjournals.com (Tue, Jan 19)
• Health-Care Stocks Watch Mass. Senate Race Today
at Barrons.com (Tue, Jan 19)
• Cyberonics' VNS Therapy(TM) System Receives Regulatory Approval in Japan
PRNewswire (Tue, Jan 19)
• Sector Snap: Medical device makers upgraded
AP (Mon, Jan 4)
• Cyberonics upgraded by Robert W. Baird
Briefing.com (Mon, Jan 4)
• 4 Ideas for a Market that Doesn't Know What It Wants
at Seeking Alpha (Tue, Dec 15)
• NYU Langone Medical Center Study Shows VNS Therapy is a Safe and Effective Treatment for Refractory Epilepsy
PRNewswire (Fri, Dec 4)
• CYBERONICS INC Financials
EDGAR Online Financials (Wed, Nov 25)
• Cyberonics, Inc.: Warming Up or Cooling Off?
at Motley Fool (Fri, Nov 20)
More Headlines for CYBX...
ANALYST
EPS Est (next year) (Apr-08) : N/A
EPS Est (in 2 years) (Apr-09) : N/A
Avg Rec (current)*: 2.8
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Cyberonics, Inc., a neuromodulation company, engages in the design, development, manufacture, and marketing of medical devices that provide vagus nerve stimulation (VNS) therapy for the treatment of epilepsy and other debilitating neurological or ...

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices